Haw Par Corporation Limited (H02.SI)
SES · SGD · Healthcare · Drug Manufacturers - General
SGD 12.83 (-1.23%) as of
Key statistics
- Market cap
- 2.84B
- P/E (TTM)
- 12.34
- Forward P/E
- 10.01
- EPS (TTM)
- 1.04
- Dividend yield
- 3.08%
- 52-week range
- 12.58 – 18.27
- Beta
- 0.16
- Revenue (TTM)
- 219.55M
- Profit margin
- 104.39%
- Analyst target
- SGD 14.60
- Volume
- 109.76k
About Haw Par Corporation Limited
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums. Further, the company is involved in the property development; and owning and letting properties; letting out of office spaces; and management support services. Haw Par Corporation Limited was incorporated in 1969 and is based in Singapore.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Singapore, Singapore
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.